97191230 - KRAZELVI

Information

• Trademark
• 97191230

• Source

• Serial Number

  97191230

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 27, 2021
  3 years ago

• Transaction Date

  April 03, 2023
  a year ago

• Status Date

  March 31, 2023
  a year ago

• Location Date

  March 31, 2023
  a year ago

• Status Code

  602

• Current Location

  TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED

  Employee Name

  SINGLETON, RUDY RENWIC

• Attorney Docket Number

  21-1694-US

  Attorney Name

  Eric R. Moran

  Law Office Assigned Location Code

  L20

• Owners

  • MIRATI THERAPEUTICS, INC.

Case File Statements

• GS0051: pharmaceuticals; pharmaceutical preparations; pharmaceutical products; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of non-small cell lung carcinoma; pharmaceutical preparations for the treatment of colorectal carcinoma; pharmaceutical preparations for the treatment of pancreatic cancer; pharmaceuticals comprising small molecules; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of infectious diseases; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of non-small cell lung carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal carcinoma; pharmaceuticals comprising small molecules for the treatment of pancreatic cancer; pharmaceuticals comprising compounds; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors; pharmaceuticals for the treatment of advanced solid tumors
• GS0421: research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals

Case File Event Statements

• 4/3/2023 - a year ago

  9 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Type: MAB2

• 3/31/2023 - a year ago

  8 - ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Type: MAB2

• 3/31/2023 - a year ago

  7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Type: ABN2

• 9/29/2022 - 2 years ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 9/29/2022 - 2 years ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 9/29/2022 - 2 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 9/28/2022 - 2 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 1/4/2022 - 2 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 12/30/2021 - 2 years ago

  1 - NEW APPLICATION ENTERED Type: NWAP